Severe Acute Respiratory Syndrome

“Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis - The BMJ” plus 3 more Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis - The BMJ Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses - The Lancet Temperature difference in the upper and lower respiratory tract influences SARS-CoV-2 replication - News-Medical.Net Probiotics may slash respiratory symptoms for overweight adults - NutraIngredients-usa.com Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis - The BMJ Posted: 28 Apr 2021 11:32 PM PDT Abstract Objective To assess the overall effect of delayed antibiotic prescribing on average symptom severity for patients with respiratory tract infections in the community,

“Two distinct types of COVID-19-associated acute respiratory distress syndrome identified - EurekAlert” plus 1 more Two distinct types of COVID-19-associated acute respiratory distress syndrome identified - EurekAlert Posted: 15 Apr 2021 12:00 AM PDT BOSTON - Approximately one in four patients hospitalized for the acute respiratory distress syndrome (ARDS) associated with severe COVID-19 infections may have a distinct phenotype (disease presentation) or biochemical profile associated with organ dysfunction, blood-clotting abnormalities and greater risk of death than patients with other, seemingly similar forms of the disease, researchers at Massachusetts General Hospital (MGH) have found. Among 263 patients admitted to intensive care units (ICUs) at MGH for respiratory failure due to severe COVID-19 infection, 70 (26.6%) had increased levels of biomarkers in the bloodstream indicating disordered blood clotting, higher inflammation, and org